Eden Research Plc offers sustainable solutions for crop protection, animal health and consumer products in the United Kingdom and rest of Europe. The company is headquartered in Oxford, Oxfordshire and currently employs 23 full-time employees. The company went IPO on 2012-05-11. The firm develops and supplies biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries. Its products include crop protection, animal health, and consumer products. Its crop protection includes Mevalone and Cedroz. Mevalone is a foliar, contact biofungicide which delivers a controlled release pattern of multiple terpene active ingredients. Cedroz is a terpene-based product developed in conjunction with Eastman Chemical Company as a post-planting solution to the problem of root-knot nematodes. The firm's Sustaine encapsulation technology is used to harness the biocidal activity of naturally occurring molecules produced by plants (terpenes) as part of their defence systems. Sustaine is used in a wide range of applications such as agricultural, animal health and consumer products
Follow-Up Questions
Eden Research PLC의 CEO는 누구입니까?
Mr. Sean Smith은 2014부터 회사에 합류한 Eden Research PLC의 Chief Executive Officer입니다.
EDNSF 주식의 가격 성능은 어떻습니까?
EDNSF의 현재 가격은 $0이며, 전 거래일에 decreased 0% 하였습니다.
Eden Research PLC의 주요 사업 주제나 업종은 무엇입니까?
Eden Research PLC은 Chemicals 업종에 속하며, 해당 부문은 Materials입니다
Eden Research PLC의 시가총액은 얼마입니까?
Eden Research PLC의 현재 시가총액은 $0입니다
Eden Research PLC는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 3명의 분석가가 Eden Research PLC에 대한 분석 평가를 실시했으며, 이는 2명의 강력한 매수, 2명의 매수, 1명의 보유, 0명의 매도, 그리고 2명의 강력한 매도를 포함합니다
